These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 8271378

  • 1. [A synthetic peptide "T22" as anti-HIV agents].
    Nakashima H, Murakami T.
    Nihon Rinsho; 1993 Sep; 51 Suppl():146-52. PubMed ID: 8271378
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Structure-activity relationships of an anti-HIV peptide, T22.
    Tamamura H, Murakami T, Masuda M, Otaka A, Takada W, Ibuka T, Nakashima H, Waki M, Matsumoto A, Yamamoto N.
    Biochem Biophys Res Commun; 1994 Dec 30; 205(3):1729-35. PubMed ID: 7811258
    [Abstract] [Full Text] [Related]

  • 5. Anti-human immunodeficiency virus activity of a novel synthetic peptide, T22 ([Tyr-5,12, Lys-7]polyphemusin II): a possible inhibitor of virus-cell fusion.
    Nakashima H, Masuda M, Murakami T, Koyanagi Y, Matsumoto A, Fujii N, Yamamoto N.
    Antimicrob Agents Chemother; 1992 Jun 30; 36(6):1249-55. PubMed ID: 1384424
    [Abstract] [Full Text] [Related]

  • 6. A wide range of medium-sized, highly cationic, alpha-helical peptides show antiviral activity against herpes simplex virus.
    Jenssen H, Andersen JH, Mantzilas D, Gutteberg TJ.
    Antiviral Res; 2004 Nov 30; 64(2):119-26. PubMed ID: 15498607
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. An anti-HIV peptide, T22, forms a highly active complex with Zn(II).
    Tamamura H, Otaka A, Murakami T, Ibuka T, Sakano K, Waki M, Matsumoto A, Yamamoto N, Fujii N.
    Biochem Biophys Res Commun; 1996 Dec 13; 229(2):648-52. PubMed ID: 8954952
    [Abstract] [Full Text] [Related]

  • 10. [Antiviral compounds: current approaches for development].
    Suzutani T, Azuma M.
    Nihon Rinsho; 1993 Jul 13; 51(7):1907-14. PubMed ID: 8366615
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Molecular parameters for the anti-human immunodeficiency virus activity of T22 ([Tyr5,12, Lys7]-polyphemusin II).
    Otaka A, Tamamura H, Terakawa Y, Masuda M, Koide T, Murakami T, Nakashima H, Matsuzaki K, Miyajima K, Ibuka T.
    Biol Pharm Bull; 1994 Dec 13; 17(12):1669-72. PubMed ID: 7735216
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Synthesis of protegrin-related peptides and their antibacterial and anti-human immunodeficiency virus activity.
    Tamamura H, Murakami T, Horiuchi S, Sugihara K, Otaka A, Takada W, Ibuka T, Waki M, Yamamoto N, Fujii N.
    Chem Pharm Bull (Tokyo); 1995 May 13; 43(5):853-8. PubMed ID: 7553971
    [Abstract] [Full Text] [Related]

  • 15. Specificity of HIV inhibition by modified antisense oligonucleotides.
    Abramova T, Blinov V, Vlassov V, Gorn V, Zarytova V, Ivanova E, Konevets D, Plyasunova O, Pokrovsky A, Sandakhchiev L.
    Nucleic Acids Symp Ser; 1991 May 13; (24):283. PubMed ID: 1841341
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A comparative study of the solution structures of tachyplesin I and a novel anti-HIV synthetic peptide, T22 ([Tyr5,12, Lys7]-polyphemusin II), determined by nuclear magnetic resonance.
    Tamamura H, Kuroda M, Masuda M, Otaka A, Funakoshi S, Nakashima H, Yamamoto N, Waki M, Matsumoto A, Lancelin JM.
    Biochim Biophys Acta; 1993 May 13; 1163(2):209-16. PubMed ID: 8490053
    [Abstract] [Full Text] [Related]

  • 19. CD4(81-92)-based peptide derivatives. Structural requirements for blockade of HIV infection, blockade of HIV-induced syncytium formation, and virostatic activity in vitro.
    Rausch DM, Lifson JD, Padgett MP, Chandrasekhar B, Lendvay J, Hwang KM, Eiden LE.
    Biochem Pharmacol; 1992 Apr 15; 43(8):1785-96. PubMed ID: 1575773
    [Abstract] [Full Text] [Related]

  • 20. [3'-Fluoro-deoxythymidine-5-fluorophosphate--an effective inhibitor of reproduction of human immunodeficiency virus in cell cultures].
    Arzumanov AA, Diatkina NB, Kukhanova MK, Kraevskiĭ AA, Semchenko FM, Eremin OG, Martynov BI.
    Bioorg Khim; 1993 Oct 15; 19(10):978-80. PubMed ID: 8274172
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.